Social Wire
AHA 25: DARE-AF: Dapagliflozin for Reducing AF Recurrence Post-Ablation
AHA 25: DARE-AF: Dapagliflozin for Reducing AF Recurrence Post-Ablation AHA Scientific Sessions 2025 - Dr Chao Jiang and ...
NVM Cardiology Meeting Reflections: AHA 25 Preview
NVM Cardiology Meeting Reflections: AHA 25 Preview NVM Cardiology Conference Reflections: What's Hot at AHA 2025? Join Pr ...
EASD 25: Prespecified Analysis of CONFIDENCE
EASD 25: Prespecified Analysis of CONFIDENCE EASD 2025 - Simultaneous finerenone and empagliflozin was a safe therapy opt ...
ESC 2025: Perspectives and Takeaways with Prof Wang
ESC 2025: Perspectives and Takeaways with Prof Wang ESC Congress 2025 - Prof Wang Jiguang (Shanghai Jiao Tong University ...
ESC 2025 - Perspectives and Takeaways with Prof Gao
ESC 2025 - Perspectives and Takeaways with Prof Gao ESC Congress 2025 - Prof Chao Gao (Air Force Medical University, CN) ...
2025 SCAI/HRS Guidelines on Transcatheter Left Atrial Appendage Occlusion
2025 SCAI/HRS Guidelines on Transcatheter Left Atrial Appendage Occlusion In this short interview, Dr Andrew Goldsweig (B ...
ESC 25 Guidelines Discussion: Management of Cardiovascular Disease and Pregnancy
ESC 25 Guidelines Discussion: Management of Cardiovascular Disease and Pregnancy ESC Congress 2025 - Updated recommendati ...
ESC 25: Cardio-oncology Highlights with Dr Susan Dent
ESC 25: Cardio-oncology Highlights with Dr Susan Dent ESC Congress 2025 - Dr Susan Dent (University of Rochester, US) joi ...
ESC 2025: Take Home Messages & Fallbesprechungen
ESC 2025: Take Home Messages & Fallbesprechungen This webinar is supported by ZOLL. Wir freuen uns Ihnen die Aufzeichnung ...